COVID-19 Science Report: Vaccines

COVID-19 Science Report: Vaccines

10.25540/xc2g-6f25

Saved in:

Bibliographic Details
Main Authors:	Jason Chin-Huat YAP, Ian Yi Han ANG, Sharon Hui Xuan TAN, Jacinta I-Pei CHEN, Ruth Frances LEWIS, Qian YANG, Rowena Kah Sin YAP, Bob Xian Yi NG, Hao Yi TAN
Other Authors:	DEAN'S OFFICE (SSH SCH OF PUBLIC HEALTH)
Format:	Working Paper/Technical Report
Published:	2020
Subjects:	COVID-19 SARS-CoV-2 2019-nCoV novel coronavirus vaccination
Online Access:	https://scholarbank.nus.edu.sg/handle/10635/164814
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

Similar Items

COVID-19 Science Report: Clinical Characteristics
by: Jason Chin-Huat YAP, et al.
Published: (2020)

COVID-19 Science Report: Diagnostics
by: Jason Chin-Huat YAP, et al.
Published: (2020)

COVID-19 Science Report: Social Distancing & Lockdowns
by: Jason Chin-Huat YAP, et al.
Published: (2020)

COVID-19 Science Report: Exit Strategies & Scenarios
by: Jason Chin-Huat YAP, et al.
Published: (2020)

COVID-19 Science Report: Therapeutics
by: Jason Chin-Huat YAP, et al.
Published: (2020)

COVID-19 Science Report: Country Journeys
by: Jason Chin-Huat YAP, et al.
Published: (2020)

Mechanistic insights of host cell fusion of SARS-CoV-1 and SARS-CoV-2 from atomic resolution structure and membrane dynamics
by: Chakraborty, Hirak, et al.
Published: (2021)

Potential Rapid Diagnostics, Vaccine and Therapeutics for 2019 Novel Coronavirus (2019-nCoV): A Systematic Review
by: Pang, Junxiong, et al.
Published: (2020)

Protection of Homologous and Heterologous Vaccine Boosters Against COVID-19 in Singapore
by: Tan, Sharon, et al.
Published: (2022)

Impact of immune enhancement on Covid-19 polyclonal hyperimmune globulin therapy and vaccine development
by: de Alwis, R., et al.
Published: (2021)

Development and characterization of a SARS-coronavirus replicon cell line
by: GE FENG
Published: (2010)

Modelling lockdown and exit strategies for COVID-19 in Singapore
by: DICKENS, BORAME SUE LEE, et al.
Published: (2021)

CHARACTERIZATION OF VIRAL-VIRAL AND VIRAL HOST INTERACTIONS THAT CONTRIBUTE TO THE REPLICATION AND PATHOGENESIS OF THE SEVERE ACUTE RESPIRATORY SYNDROME VIRUS (SARS-COV)
by: KENG CHOONG TAT
Published: (2011)

Memory T Cell Responses Targeting the SARS Coronavirus Persist up to 11 Years Post-Infection
by: Ng, Oi Wing, et al.
Published: (2016)

Vaccines and allergic reactions: The past, the current COVID-19 pandemic, and future perspectives
by: Sampath, V, et al.
Published: (2022)

Neurology of COVID-19 in Singapore
by: Koh, JS, et al.
Published: (2020)

Co-incidence of BA.1 and BA.2 at the start of Singapore's Omicron wave revealed by community and university campus wastewater surveillance
by: Chua, Desmond Feng Jun, et al.
Published: (2023)

Linear B-cell epitopes in the spike and nucleocapsid proteins as markers of SARS-CoV-2 exposure and disease severity
by: Siti Naqiah Amrun, et al.
Published: (2020)

Importations of COVID-19 into African countries and risk of onward spread
by: Sun, H., et al.
Published: (2021)

The polybasic insert, the RBD of the SARS-CoV-2 spike protein, and the feline coronavirus – evolved or yet to evolve
by: Budhraja, Anshul, et al.
Published: (2022)

The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak- A n update on the status
by: Guo, Y.-R., et al.
Published: (2021)

A phase I/II randomized, double-blinded, placebo-controlled trial of a self-amplifying Covid-19 mRNA vaccine
by: Low, Jenny G., et al.
Published: (2023)

How Should the Rehabilitation Community Prepare for 2019-nCoV?
by: Choon-Huat Koh, G, et al.
Published: (2022)

COVID-19 severity and waning immunity after up to 4 mRNA vaccine doses in 73 608 patients with cancer and 621 475 matched controls in Singapore: a nationwide cohort study
by: Tan, Wei Chong, et al.
Published: (2024)

SARS-CoV-2 Humoral Immunity Persists Following Rituximab Therapy
by: Lu, Liangjian, et al.
Published: (2023)

Robust sars?cov?2 antibody responses in asian covid?naïve subjects 180 days after two doses of bnt162b2 mrna covid?19 vaccine
by: Lau, Chin-Shern, et al.
Published: (2022)

Combination therapy using inhalable GapmeR and recombinant ACE2 for COVID-19
by: Verma, Navin Kumar, et al.
Published: (2020)

The Effects of Heterologous Immunization with Prime-Boost COVID-19 Vaccination against SARS-CoV-2
by: Ho, Tzu-Chuan, et al.
Published: (2022)

EVALUATION OF ADAPTIVE IMMUNITY INDUCED BY VACCINATION AND INFECTION
by: NICHOLAS KHOO KIM HUAT
Published: (2023)

TOWARDS THE DEVELOPMENT OF ANTIMICROBIAL AGENTS AGAINST INFECTIOUS DISEASES
by: HO WEI SHEN
Published: (2024)

Longitudinal wastewater-based surveillance for SARS-CoV-2 in high-density student dormitories in Singapore
by: Ng, Wei Jie, et al.
Published: (2024)

Early pathogenesis profiles across SARS-CoV-2 variants in K18-hACE2 mice revealed differential triggers of lung damages
by: Aw, Zhen Qin, et al.
Published: (2023)

A novel virtual screening procedure identifies Pralatrexate as inhibitor of SARS-CoV-2 RdRp and it reduces viral replication in vitro
by: Zhang, Haiping, et al.
Published: (2021)

Results from a systematic programme of evaluating COVID-19 reinfection cases in the early phase of the pandemic, Singapore
by: Tan, Glorijoy Shi En, et al.
Published: (2023)

Extrapulmonary manifestations and complications of severe acute respiratory syndrome coronavirus 2 infection: a systematic review.
by: Cho, Jiacai, et al.
Published: (2021)

Third dose of BNT162b2 improves immune response in liver transplant recipients to ancestral strain but not Omicron BA.1 and XBB
by: Chang, Zi Wei, et al.
Published: (2023)

Coronavirus disease 2019 (COVID-19): an evidence map of medical literature
by: LIU NAN, et al.
Published: (2020)

COVID-19 Vaccines Help with Herd Immunity
by: Usa Lek-Uthai
Published: (2022)

Waning of specific antibodies against Delta and Omicron variants five months after a third dose of BNT162b2 SARS-CoV-2 vaccine in elderly individuals
by: Goh, Yun Shan, et al.
Published: (2023)

The spike and 3A proteins of severe acute respiratory syndrome coronavirus (SARS-CoV): Expressions and interactions in mammalian cells
by: SOONG POH LOONG
Published: (2010)